HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Niewoehner, D. E. Articles by Kesten, S. Search for Related Content PubMed PubMed Citation Articles by Niewoehner, D. E. Articles by Kesten, S.

Risk Indexes for Exacerbations and Hospitalizations Due to COPD^*

^* From the Departments of Medicine at Veterans Affairs Medical Centers in Minneapolis, MN (Drs. Niewoehner and Rice), Palo Alto, CA (Dr. Kuschner), Houston, TX (Dr. Sharafkhaneh), Indianapolis, IN (Dr. Sarosi), and Reno, NV (Dr. Krumpe); the Duke Clinical Research Institute (Dr. Lokhnygina and Ms. Pieper), Durham, NC; and Boehringer-Ingelheim Pharmaceuticals (Dr. Kesten), Ridgefield, CT.

Correspondence to: Dennis E. Niewoehner, MD, FCCP, Veterans Affairs Medical Center, One Veterans Dr, Minneapolis, MN 55417; e-mail: niewo001{at}umn.edu

Abstract

Objective: The ability to predict exacerbations in patients with COPD might permit more rational use of preventive interventions. Our objective was to develop risk indexes for exacerbations and hospitalizations due to exacerbations that might be applied to the individual patient.

Methods: Spirometry, demographics, and medical history were obtained at baseline in 1,829 patients with moderate-to-very severe COPD who entered a trial of inhaled tiotropium. Information about exacerbations and hospitalizations due to exacerbation was collected during the 6-month follow-up period. Analyses of first outcomes were modeled using univariable and multivariable Cox proportional hazards regressions.

Results: During follow-up, 551 patients had at least one exacerbation and 151 patients had at least one hospitalization due to exacerbation. In the multivariable model for exacerbation, older age, percentage of predicted FEV₁, duration of COPD, a productive cough, antibiotic or systemic corticosteroid use for COPD in the prior year, hospitalization for COPD in the prior year, and theophylline use at baseline predicted a higher risk. In the multivariable model for hospitalization, older age, percentage of predicted FEV₁, unscheduled clinic/emergency department visits for COPD in the prior year, any cardiovascular comorbidity, and prednisone use at baseline were associated with greater risk. Both the exacerbation and the hospitalization models provided moderately good discrimination, the validated concordance indexes being 0.66 and 0.73, respectively. Methods for calculating risk in individual patients are provided.

Conclusions: Spirometry along with a few questions directed to the patient are strongly predictive of exacerbations and related hospitalizations over the ensuing 6 months.

Key Words: COPD • exacerbations • risk models

This article has been cited by other articles:

				J.-P. Zheng, L. Yang, Y. M. Wu, P. Chen, Z. G. Wen, W.-J. Huang, Y. Shi, C.-Z. Wang, S.-G. Huang, T.-y. Sun, et al. The Efficacy and Safety of Combination Salmeterol (50 {micro}g)/Fluticasone Propionate (500 {micro}g) Inhalation Twice Daily Via Accuhaler in Chinese Patients With COPD Chest, December 1, 2007; 132(6): 1756 - 1763. [Abstract] [Full Text] [PDF]

				A. Mohan, S. P. Bhatt, R. Guleria, and D. E. Niewoehner Risk Indexes for Exacerbations Dueto COPD: Need To Validate Using Broader Criteria Chest, August 1, 2007; 132(2): 735 - 736. [Full Text] [PDF]